aid: alloplex-biotherapeutics
name: Alloplex Biotherapeutics
description: >-
  Alloplex Biotherapeutics, Inc. is a privately held clinical-stage cellular immunotherapy company
  founded in 2016 and headquartered in Woburn, Massachusetts, with a wholly owned subsidiary,
  Alloplex Australia Pty Ltd, in Adelaide, South Australia. It develops non-engineered, autologous
  multi-cellular therapies intended to retrain a patient's own immune system against solid tumors
  and autoimmune disease. Its ENLIST platform uses an irradiated, engineered melanoma cell line
  expressing multiple immunomodulatory factors to activate, differentiate and expand a patient's
  peripheral blood mononuclear cells; the resulting product, SUPLEXA, is manufactured by a defined,
  GMP-compatible process that uses no genetic engineering and no feeder cells and yields a full
  course of treatment from a small blood draw in roughly one month. The first-in-human Phase 1
  SUPLEXA-101 trial, conducted in Australia in 35 patients with metastatic solid tumors who had
  exhausted standard options, met its endpoints, and the FDA granted SUPLEXA Fast Track designation
  for MSI-H colorectal cancer. Alloplex Biotherapeutics runs no developer program and publishes no
  product API, developer portal, SDK or API documentation; the only machine-readable surface
  reachable without credentials is the WordPress REST content API behind alloplexbio.com,
  catalogued here.
image: https://alloplexbio.com/wp-content/uploads/2021/05/mark@2x.png
url: https://raw.githubusercontent.com/api-evangelist/alloplex-biotherapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enriched
specificationVersion: '0.20'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- biotechnology
- cell-therapy
- immunotherapy
- oncology
- cancer
- clinical-trials
- life-sciences
- drug-development
- autoimmunity
- content-api
apis:
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-discovery-api
  name: Alloplex Biotherapeutics Discovery API
  description: Route, type, taxonomy and status discovery documents.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - discovery
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-discovery-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-media-api
  name: Alloplex Biotherapeutics Media API
  description: >-
    Media library (225 attachments at harvest time), including PDF executive summaries and press assets.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - media
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-media-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-oembed-api
  name: Alloplex Biotherapeutics Oembed API
  description: oEmbed 1.0 provider endpoint for alloplexbio.com URLs.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - oembed
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-oembed-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-pages-api
  name: Alloplex Biotherapeutics Pages API
  description: >-
    Corporate pages (19 published at harvest time) — About, Investors, Scientists, Information for Patients,
    Media and Press, Media Kit, FAQ, Releases and Updates, Terms of use, Privacy Policy, Contact, and
    the shareholder-portal pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - pages
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-pages-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-posts-api
  name: Alloplex Biotherapeutics Posts API
  description: >-
    Press releases, scientific and clinical news, conference notes and opinion pieces (61 published at
    harvest time). Unlike many corporate WordPress deployments, content.rendered and excerpt.rendered
    are fully populated here.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - posts
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-posts-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-search-api
  name: Alloplex Biotherapeutics Search API
  description: Cross-content search across published posts and pages.
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - search
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-search-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
- aid: alloplex-biotherapeutics:alloplex-biotherapeutics-taxonomy-api
  name: Alloplex Biotherapeutics Taxonomy API
  description: >-
    Categories and tags. Categories holds 11 terms (company-news, clinical-news, scientific-news, research-news,
    conferences, media-coverage, opinion, backgrounder, diary-marker, audio-video, uncategorized); the
    tags taxonomy is registered but empty (0 terms).
  humanURL: https://developer.wordpress.org/rest-api/
  baseURL: https://alloplexbio.com/wp-json
  tags:
  - taxonomy
  properties:
  - type: OpenAPI
    url: openapi/alloplex-biotherapeutics-taxonomy-api-openapi.yml
  - type: Authentication
    url: authentication/alloplex-biotherapeutics-authentication.yml
  - type: ErrorCatalog
    url: errors/alloplex-biotherapeutics-problem-types.yml
  - type: Conventions
    url: conventions/alloplex-biotherapeutics-conventions.yml
  - type: DataModel
    url: data-model/alloplex-biotherapeutics-data-model.yml
  - type: JSONLD
    url: json-ld/alloplex-biotherapeutics-json-ld.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Overlay
  url: overlays/alloplex-biotherapeutics-content-overlay.yaml
- type: Website
  url: https://alloplexbio.com/
- type: About
  url: https://alloplexbio.com/about/
- type: Science
  url: https://alloplexbio.com/scientists/
- type: Investors
  url: https://alloplexbio.com/investors/
- type: News
  url: https://alloplexbio.com/newsroom/
- type: Blog
  url: https://alloplexbio.com/releases-and-updates/
- type: BlogRSS
  url: https://alloplexbio.com/feed/
- type: InTheNews
  url: https://alloplexbio.com/in-the-news/
- type: MediaKit
  url: https://alloplexbio.com/presskitoct24/
- type: Publications
  url: https://alloplexbio.com/publications/
- type: InformationForPatients
  url: https://alloplexbio.com/information-for-patients/
- type: FAQ
  url: https://alloplexbio.com/faq/
- type: Contact
  url: https://alloplexbio.com/contact/
- type: Support
  url: https://alloplexbio.com/contact/
- type: Login
  url: https://alloplexbio.com/portal-login/
- type: TermsOfService
  url: https://alloplexbio.com/terms/
- type: PrivacyPolicy
  url: https://alloplexbio.com/privacy-policy/
- type: LinkedIn
  url: https://www.linkedin.com/company/alloplex-biotherapeutics
- type: Sitemap
  url: https://alloplexbio.com/sitemap_index.xml
- type: SecondaryMarket
  url: https://forgeglobal.com/alloplex-biotherapeutics_stock/
- type: Authentication
  url: authentication/alloplex-biotherapeutics-authentication.yml
- type: Conventions
  url: conventions/alloplex-biotherapeutics-conventions.yml
- type: Conformance
  url: conformance/alloplex-biotherapeutics-conformance.yml
- type: ErrorCatalog
  url: errors/alloplex-biotherapeutics-problem-types.yml
- type: Lifecycle
  url: lifecycle/alloplex-biotherapeutics-lifecycle.yml
- type: DataModel
  url: data-model/alloplex-biotherapeutics-data-model.yml
- type: JSONLD
  url: json-ld/alloplex-biotherapeutics-json-ld.yml
- type: WellKnown
  url: well-known/alloplex-biotherapeutics-well-known.yml
- type: DomainSecurity
  url: security/alloplex-biotherapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/alloplex-biotherapeutics-llms.txt
- type: AgentSkill
  url: skills/_index.yml
x-enrichment:
  date: '2026-08-06'
  status: enriched
  artifacts_added: 17
  pass: local-v1
x-coverage:
  state: covered
  reason: no-developer-program
  detail: >-
    Alloplex Biotherapeutics is a clinical-stage biotech that runs no developer program — /developers/,
    /api/ and every /.well-known/ path return 404 against a verified negative control — but its
    corporate WordPress site exposes a genuinely anonymous, machine-readable REST content API at
    /wp-json/ (61 posts, 19 pages, 225 media items, populated content bodies), which is what this
    profile catalogues; the site also registers a WordPress MCP adapter and the Abilities API, but
    both return 401 rest_forbidden anonymously so no agent surface is claimed.
  evidence:
  - url: https://alloplexbio.com/wp-json/
    status: 200
  - url: https://alloplexbio.com/wp-json/wp/v2/posts?per_page=1
    status: 200
  - url: https://alloplexbio.com/wp-json/mcp/mcp-adapter-default-server
    status: 401
  - url: https://alloplexbio.com/.well-known/agent-card.json
    status: 404
  - url: https://alloplexbio.com/openapi.json
    status: 404
  - url: https://alloplexbio.com/.well-known/THIS-SHOULD-404-control
    status: 404
  checked: '2026-08-06'